FDA 483 - Pfizer Manufacturing Deutschland GmbH

Pfizer Manufacturing Deutschland GmbH in Freiburg im Breisgau was inspected and cited for significant deficiencies in its quality system. Observations included inadequate written records for drug complaint investigations and unexplained discrepancies, as well as insufficient written procedures for cleaning and maintenance. These issues indicate a lack of robust control over critical manufacturing processes and documentation.